Given the recent talk about leronlimab’s cancer results, more specifically CTCs, I figured I’d share a recent article from Dr. BP on CTCs. CTC is a valuable measurement for CYDY and the path forward. Incelldx has a new patent for detecting PD-L1 on CTCs, so the science is improving. Let’s get a PR/8K with the CTC/CAML data so the trial enrollment can speed up rand results can be announced.

https://lsc-pagepro.mydigitalpublication.com/...8&pp=1